New insights on disintegrin-receptor interactions: Eristostatin and melanoma cells

Mary Ann McLane, M. A. Kuchar, C. Brando, D. Santoli, C. A. Paquette-Straub, Mary Beth Miele

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Viper venom disintegrins have been used frequently to study the cellular receptors which characterize various types of cells, including platelets, endothelial cells and cancer cells. While the majority of such analyses have pointed to involvement of integrin receptors αvβ3, α5β1 or αIIbβ3, this may not always be so. Eristostatin, from Eristocophis macmahoni, is a potent inhibitor of ADP-induced platelet aggregation as well as of human and murine melanoma metastases in mouse model systems. This disintegrin requires an RGDW motif, as well as an intact C-terminus, in order to interact with both platelets and four different types of melanoma cells. Eristostatin causes nonmetastatic SBc12 melanoma cells to show higher susceptibility to specific killing by NK-like TALL-104 cells. While it is known that eristostatin binds to αIIbβ3 on platelets, the receptor with which eristostatin binds to the melanoma cells has not yet been identified.

Original languageEnglish (US)
Pages (from-to)177-182
Number of pages6
JournalHaemostasis
Volume31
Issue number3-6
StatePublished - Dec 1 2001

Fingerprint

Disintegrins
Melanoma
Blood Platelets
Viper Venoms
Platelet Aggregation
Integrins
Adenosine Diphosphate
eristostatin
Endothelial Cells
Neoplasm Metastasis
Neoplasms

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

McLane, M. A., Kuchar, M. A., Brando, C., Santoli, D., Paquette-Straub, C. A., & Miele, M. B. (2001). New insights on disintegrin-receptor interactions: Eristostatin and melanoma cells. Haemostasis, 31(3-6), 177-182.
McLane, Mary Ann ; Kuchar, M. A. ; Brando, C. ; Santoli, D. ; Paquette-Straub, C. A. ; Miele, Mary Beth. / New insights on disintegrin-receptor interactions : Eristostatin and melanoma cells. In: Haemostasis. 2001 ; Vol. 31, No. 3-6. pp. 177-182.
@article{ddc4b97235fb4204aedb9595b24935a7,
title = "New insights on disintegrin-receptor interactions: Eristostatin and melanoma cells",
abstract = "Viper venom disintegrins have been used frequently to study the cellular receptors which characterize various types of cells, including platelets, endothelial cells and cancer cells. While the majority of such analyses have pointed to involvement of integrin receptors αvβ3, α5β1 or αIIbβ3, this may not always be so. Eristostatin, from Eristocophis macmahoni, is a potent inhibitor of ADP-induced platelet aggregation as well as of human and murine melanoma metastases in mouse model systems. This disintegrin requires an RGDW motif, as well as an intact C-terminus, in order to interact with both platelets and four different types of melanoma cells. Eristostatin causes nonmetastatic SBc12 melanoma cells to show higher susceptibility to specific killing by NK-like TALL-104 cells. While it is known that eristostatin binds to αIIbβ3 on platelets, the receptor with which eristostatin binds to the melanoma cells has not yet been identified.",
author = "McLane, {Mary Ann} and Kuchar, {M. A.} and C. Brando and D. Santoli and Paquette-Straub, {C. A.} and Miele, {Mary Beth}",
year = "2001",
month = "12",
day = "1",
language = "English (US)",
volume = "31",
pages = "177--182",
journal = "Haemostasis",
issn = "0301-0147",
publisher = "S. Karger AG",
number = "3-6",

}

McLane, MA, Kuchar, MA, Brando, C, Santoli, D, Paquette-Straub, CA & Miele, MB 2001, 'New insights on disintegrin-receptor interactions: Eristostatin and melanoma cells', Haemostasis, vol. 31, no. 3-6, pp. 177-182.

New insights on disintegrin-receptor interactions : Eristostatin and melanoma cells. / McLane, Mary Ann; Kuchar, M. A.; Brando, C.; Santoli, D.; Paquette-Straub, C. A.; Miele, Mary Beth.

In: Haemostasis, Vol. 31, No. 3-6, 01.12.2001, p. 177-182.

Research output: Contribution to journalArticle

TY - JOUR

T1 - New insights on disintegrin-receptor interactions

T2 - Eristostatin and melanoma cells

AU - McLane, Mary Ann

AU - Kuchar, M. A.

AU - Brando, C.

AU - Santoli, D.

AU - Paquette-Straub, C. A.

AU - Miele, Mary Beth

PY - 2001/12/1

Y1 - 2001/12/1

N2 - Viper venom disintegrins have been used frequently to study the cellular receptors which characterize various types of cells, including platelets, endothelial cells and cancer cells. While the majority of such analyses have pointed to involvement of integrin receptors αvβ3, α5β1 or αIIbβ3, this may not always be so. Eristostatin, from Eristocophis macmahoni, is a potent inhibitor of ADP-induced platelet aggregation as well as of human and murine melanoma metastases in mouse model systems. This disintegrin requires an RGDW motif, as well as an intact C-terminus, in order to interact with both platelets and four different types of melanoma cells. Eristostatin causes nonmetastatic SBc12 melanoma cells to show higher susceptibility to specific killing by NK-like TALL-104 cells. While it is known that eristostatin binds to αIIbβ3 on platelets, the receptor with which eristostatin binds to the melanoma cells has not yet been identified.

AB - Viper venom disintegrins have been used frequently to study the cellular receptors which characterize various types of cells, including platelets, endothelial cells and cancer cells. While the majority of such analyses have pointed to involvement of integrin receptors αvβ3, α5β1 or αIIbβ3, this may not always be so. Eristostatin, from Eristocophis macmahoni, is a potent inhibitor of ADP-induced platelet aggregation as well as of human and murine melanoma metastases in mouse model systems. This disintegrin requires an RGDW motif, as well as an intact C-terminus, in order to interact with both platelets and four different types of melanoma cells. Eristostatin causes nonmetastatic SBc12 melanoma cells to show higher susceptibility to specific killing by NK-like TALL-104 cells. While it is known that eristostatin binds to αIIbβ3 on platelets, the receptor with which eristostatin binds to the melanoma cells has not yet been identified.

UR - http://www.scopus.com/inward/record.url?scp=0035742109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035742109&partnerID=8YFLogxK

M3 - Article

C2 - 11910183

AN - SCOPUS:0035742109

VL - 31

SP - 177

EP - 182

JO - Haemostasis

JF - Haemostasis

SN - 0301-0147

IS - 3-6

ER -

McLane MA, Kuchar MA, Brando C, Santoli D, Paquette-Straub CA, Miele MB. New insights on disintegrin-receptor interactions: Eristostatin and melanoma cells. Haemostasis. 2001 Dec 1;31(3-6):177-182.